IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 129 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $163,000 | -32.4% | 14,623 | -37.4% | 0.02% | -47.9% |
Q2 2020 | $241,000 | +33.9% | 23,359 | +100.6% | 0.05% | +26.3% |
Q1 2018 | $180,000 | -76.3% | 11,644 | -76.6% | 0.04% | -87.7% |
Q4 2016 | $758,000 | -36.2% | 49,750 | -35.2% | 0.31% | -29.1% |
Q3 2016 | $1,189,000 | +56.2% | 76,762 | +30.8% | 0.44% | +22.8% |
Q2 2016 | $761,000 | +384.7% | 58,701 | +292.6% | 0.36% | +482.0% |
Q1 2016 | $157,000 | -77.6% | 14,951 | -74.7% | 0.06% | -67.9% |
Q4 2015 | $701,000 | +75.2% | 59,211 | +54.2% | 0.19% | -3.6% |
Q3 2015 | $400,000 | -60.7% | 38,388 | -56.2% | 0.20% | -12.8% |
Q2 2015 | $1,018,000 | +401.5% | 87,720 | +557.2% | 0.23% | +175.6% |
Q4 2014 | $203,000 | – | 13,347 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
EMC Capital Management | 43,315 | $417 | 0.31% |